High levels of visfatin are observed in patients with obesity, type 2 diabetes mellitus, chronic inflammatory conditions and cancer, and an association between serum visfatin levels and cardiovascular disease has recently been observed in patients with type 2 diabetes [123,124,125]. Here, NAMPT is linked to diabetes mellitus.